31 results
6-K
EX-99.2
BLU
Bellus Health Inc
27 Apr 23
Material Change Report
6:04am
the meaning set forth in Section 6.1(c).
“LSE” means the London Stock Exchange.
“Major Supplier” has the meaning set forth in Section 34 of Schedule C … customer, supplier, or subcontractor in the ordinary course of business under the terms of any Contract to which the relevant party is a party or under
6-K
EX-99.1
BLU
Bellus Health Inc
29 Mar 23
Current report (foreign)
5:26pm
payments when due, default under their agreements with us, become insolvent or declare bankruptcy, or a supplier may determine that it will no longer … deal with us as a customer. In addition, a customer or supplier could be adversely affected by any of the liquidity or other risks that are described
6-K
BLU
Bellus Health Inc
23 Dec 04
Current report (foreign)
12:00am
or its
Affiliates, Neurochem and Centocor shall cooperate to as soon as possible
qualify a second supplier in Canada (which, if acceptable to Centocor … , may be a
supplier proposed by Neurochem) to be used to Manufacture the Product pursuant
to the Supply Agreement as a back-up to the initial manufacturer
40-F
2006 FY
EX-1
BLU
Bellus Health Inc
22 Mar 06
Annual report (Canada)
12:00am
suppliers or
product manufacturers (whether the change is attributable to us
or the supplier or manufacturer) could delay
40-F
2007 FY
EX-99.1
BLU
Bellus Health Inc
14 Mar 08
Annual report (Canada)
12:00am
or product manufacturers (whether the change is attributable to us or the supplier or manufacturer) could delay clinical studies, regulatory submissions
6-K
EX-99.2
vsvxmpk u7mjim
30 Mar 23
Notice of Annual and Special Meeting of Shareholders
11:22am
6-K
EX-99.1
7qo3t
19 May 23
Current report (foreign)
5:27pm
40-F/A
EX-99.1
ecc8ehqpyjbi7
27 Mar 07
Annual report (Canada) (amended)
12:00am
6-K
EX-99.1
c3pwnlss
2 Jun 23
Notice of Annual and Special Meeting of Shareholders
4:25pm
SUPPL
0ss0u6rus
4 Mar 05
Supplemental materials (foreign)
12:00am
6-K
EX-99.1
lug uudo0r
14 Nov 22
Open Market Sale Agreementsm
5:19pm
6-K
EX-99.1
yj5ajx0n
23 Dec 20
Open Market Sale Agreementsm
5:06pm
F-10/A
rzea1 muvn37
3 Mar 05
Registration of securities (Canada) (amended)
12:00am
F-10/A
ycrizce9pqsc h5vb2n
23 May 07
Registration of securities (Canada) (amended)
12:00am
F-10
mqboz1378 vjy2c5c9mx
9 May 07
Registration of securities (Canada)
12:00am
F-10
uo8xdl
23 Feb 05
Registration of securities (Canada)
12:00am
6-K
EX-99.2
od21c7 yudfvw6i
14 Jul 22
BELLUS Health Announces Pricing of US$153 Million Public Offering in Canada and the United States
4:46pm
6-K
EX-99.2
tckeox5r6hsuuj0h
15 Dec 21
BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the United States
5:15pm
6-K
EX-99.1
h7nizrxo
20 Oct 20
As Representatives of the several Underwriters
4:43pm
F-10/A
EX-3.1
qx55nv2d
4 Sep 19
Registration of securities (Canada) (amended)
4:44pm